arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Mineralys Therapeutics, Inc.

MLYS Health Care Biotechnology: Pharmaceutical Preparations
$23.69
▼ -5.4% Today
as of Jun 7, 07:21 ET
Last 30 days -8.50% Apr 28 → Jun 05
$23.06 $25.34 $27.62 $29.89 $32.17 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$24.80
High
$25.09
Low
$23.34
Volume
$4M
Avg Vol
$1M
Mkt Cap
$2.6B
P/E (TTM)
Beta
52w High
$47.65
52w Low
$12.59
Div Yield
Shares Out
$82M

Overview

52-week range
$13
$48
32% of range
Avg surprise (last 2)
+15.2%
Avg reaction (last 2)
+2.7%
100% positive
Latest IV / EM
107%
EM ±14.9% · $23 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.13$-0.92$-0.72$-0.52$-0.31 Actual $-0.31Actual $-0.57Actual $-0.70Actual $-0.83Actual $-1.13Actual $-0.79Est $-1.02Actual $-0.66Actual $-0.52Actual $-0.47Est $-0.51 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-56M$-52M$-48M$-43M$-39M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.47 $-0.51 +7.8% +40.5% +2.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.52 financials
Mon Jun 30, 2025Jun 2025 $-0.66 financials
Mon May 12, 2025Mar/2025 $-0.79 $-1.02 +22.6% +2.5% earnings
Mon Sep 30, 2024Sep 2024 $-1.13 financials
Sun Jun 30, 2024Jun 2024 $-0.83 financials
Sun Mar 31, 2024Mar 2024 $-0.70 financials
Sat Sep 30, 2023Sep 2023 $-0.57 financials
Fri Jun 30, 2023Jun 2023 $-0.31 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-45M$-41M$-47M$-44M$-60M$-45M
Net income$-39M$-37M$-43M$-42M$-56M$-41M
EPS (diluted)$-0.47$-0.52$-0.66$-0.79$-1.13$-0.83

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$113M$173M$218M$102M$165M$114M$97M$68M
Inventory
Total current assets$652M$661M$600M$335M$355M$205M$268M$318M
Total assets$653M$662M$600M$336M$355M$206M$268M$318M
Long-term debt
Total liabilities
Total equity$638M$647M$576M$314M$342M$191M$237M$290M

Implied volatility — last 90 days

102%104%107%109%112% Jun 07 — IV 107% · EM ±14.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.